Thursday, March 28, 2024
Home Tags Nasdaq:MORF

Tag: Nasdaq:MORF

Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering

0
WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of...

Morphic Announces Corporate Highlights and Financial Results for the Full Year...

0
Announced positive preliminary results from Phase 1 SAD clinical trial of MORF-057 AbbVie exercised license option to αvβ6 integrin inhibitor program for...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News